BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 24285725)

  • 1. p53-induced miR-15a/16-1 and AP4 form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer.
    Shi L; Jackstadt R; Siemens H; Li H; Kirchner T; Hermeking H
    Cancer Res; 2014 Jan; 74(2):532-42. PubMed ID: 24285725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.
    Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X
    Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AP4 activates cell migration and EMT mediated by p53 in MDA-MB-231 breast carcinoma cells.
    Chen S; Chiu SK
    Mol Cell Biochem; 2015 Sep; 407(1-2):57-68. PubMed ID: 26037074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulated miR-15a mediates the epithelial-mesenchymal transition in renal tubular epithelial cells promoted by high glucose.
    Sun T; Yang J; Dong W; Wang R; Ma P; Kang P; Zhang H; Xie C; Du J; Zhao L
    Biosci Biotechnol Biochem; 2014; 78(8):1363-70. PubMed ID: 25130738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
    Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
    Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. USP22 drives colorectal cancer invasion and metastasis via epithelial-mesenchymal transition by activating AP4.
    Li Y; Yang Y; Li J; Liu H; Chen F; Li B; Cui B; Liu Y
    Oncotarget; 2017 May; 8(20):32683-32695. PubMed ID: 28427243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.
    Wu J; Wu G; Lv L; Ren YF; Zhang XJ; Xue YF; Li G; Lu X; Sun Z; Tang KF
    Carcinogenesis; 2012 Mar; 33(3):519-28. PubMed ID: 22198213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of TRPS1 stimulates epithelial-mesenchymal transition and metastasis through repression of FOXA1.
    Huang JZ; Chen M; Zeng M; Xu SH; Zou FY; Chen D; Yan GR
    J Pathol; 2016 Jun; 239(2):186-96. PubMed ID: 26969828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR‑145.
    Ren D; Wang M; Guo W; Zhao X; Tu X; Huang S; Zou X; Peng X
    Int J Oncol; 2013 Apr; 42(4):1473-81. PubMed ID: 23404342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer.
    Xu Q; Sun Q; Zhang J; Yu J; Chen W; Zhang Z
    Carcinogenesis; 2013 Mar; 34(3):539-49. PubMed ID: 23188671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-302c represses epithelial-mesenchymal transition and metastasis by targeting transcription factor AP-4 in colorectal cancer.
    Ma W; Liu B; Li J; Jiang J; Zhou R; Huang L; Li X; He X; Zhou Q
    Biomed Pharmacother; 2018 Sep; 105():670-676. PubMed ID: 29906744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of miR-638 promotes invasion and proliferation by regulating SOX2 and induces EMT in NSCLC.
    Xia Y; Wu Y; Liu B; Wang P; Chen Y
    FEBS Lett; 2014 Jun; 588(14):2238-45. PubMed ID: 24842609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer.
    Raza U; Saatci Ö; Uhlmann S; Ansari SA; Eyüpoğlu E; Yurdusev E; Mutlu M; Ersan PG; Altundağ MK; Zhang JD; Doğan HT; Güler G; Şahin Ö
    Oncotarget; 2016 Aug; 7(31):49859-49877. PubMed ID: 27409664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions.
    Siemens H; Jackstadt R; Hünten S; Kaller M; Menssen A; Götz U; Hermeking H
    Cell Cycle; 2011 Dec; 10(24):4256-71. PubMed ID: 22134354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF.
    Sun CY; She XM; Qin Y; Chu ZB; Chen L; Ai LS; Zhang L; Hu Y
    Carcinogenesis; 2013 Feb; 34(2):426-35. PubMed ID: 23104180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis.
    Wang DT; Ma ZL; Li YL; Wang YQ; Zhao BT; Wei JL; Qi X; Zhao XT; Jin YX
    Oncol Rep; 2013 Jul; 30(1):492-8. PubMed ID: 23670238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AP4 is a mediator of epithelial-mesenchymal transition and metastasis in colorectal cancer.
    Jackstadt R; Röh S; Neumann J; Jung P; Hoffmann R; Horst D; Berens C; Bornkamm GW; Kirchner T; Menssen A; Hermeking H
    J Exp Med; 2013 Jul; 210(7):1331-50. PubMed ID: 23752226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-300 promotes proliferation and EMT-mediated colorectal cancer migration and invasion by targeting p53.
    Wang L; Yu P
    Oncol Rep; 2016 Dec; 36(6):3225-3232. PubMed ID: 27779716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The miR-200 family regulates the epithelial-mesenchymal transition induced by EGF/EGFR in anaplastic thyroid cancer cells.
    Zhang Z; Liu ZB; Ren WM; Ye XG; Zhang YY
    Int J Mol Med; 2012 Oct; 30(4):856-62. PubMed ID: 22797360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.
    Luo Q; Li X; Li J; Kong X; Zhang J; Chen L; Huang Y; Fang L
    Int J Oncol; 2013 Oct; 43(4):1212-8. PubMed ID: 23900351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.